Resting state functional connectivity and treatment response in late-life depression

Psychiatry Res. 2013 Dec 30;214(3):313-21. doi: 10.1016/j.pscychresns.2013.08.007. Epub 2013 Oct 18.

Abstract

Indices of functional connectivity in the default mode network (DMN) are promising neural markers of treatment response in late-life depression. We examined the differences in DMN functional connectivity between treatment-responsive and treatment-resistant depressed older adults. Forty-seven depressed older adults underwent MRI scanning pre- and post-pharmacotherapy. Forty-six never depressed older adults underwent MR scanning as comparison subjects. Treatment response was defined as achieving a Hamilton Depression Rating Scale of 10 or less post-treatment. We analyzed resting state functional connectivity using the posterior cingulate cortex as the seed region-of-interest. The resulting correlation maps were employed to investigate between-group differences. Additionally we examined the association between white matter hyperintensity burden and functional connectivity results. Comparison of pre- and post-treatment scans of depressed participants revealed greater post-treatment functional connectivity in the frontal precentral gyrus. Relative to treatment-responsive participants, treatment-resistant participants had increased functional connectivity in the left striatum. When adjusting for white matter hyperintensity burden, the observed differences lost significance for the PCC-prefrontal functional connectivity, but not for the PCC-striatum functional connectivity. The post-treatment "frontalization" of the DMN connectivity suggests a normalizing effect of antidepressant treatment. Moreover, our study confirms the central role of white matter lesions in disrupting brain functional connectivity.

Trial registration: ClinicalTrials.gov NCT00177294 NCT00177671 NCT00696292.

Keywords: Default Mode Network; Late-life depression; MRI; Treatment response; White matter hyperintensity.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Antidepressive Agents / therapeutic use*
  • Brain / drug effects*
  • Brain / pathology
  • Brain / physiopathology*
  • Brain Mapping
  • Case-Control Studies
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / physiopathology*
  • Female
  • Gyrus Cinguli / drug effects
  • Gyrus Cinguli / pathology
  • Gyrus Cinguli / physiopathology
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neostriatum / drug effects
  • Neostriatum / pathology
  • Neostriatum / physiopathology
  • Nerve Fibers, Myelinated / pathology
  • Rest*
  • Treatment Outcome

Substances

  • Antidepressive Agents

Associated data

  • ClinicalTrials.gov/NCT00177294
  • ClinicalTrials.gov/NCT00177671
  • ClinicalTrials.gov/NCT00696292